当前位置:首页 - 行情中心 - 泓博医药(301230) - 财务分析 - 现金流量表

泓博医药

(301230)

  

流通市值:26.59亿  总市值:48.28亿
流通股本:7686.03万   总股本:1.40亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金417,894,006.74259,334,867.87118,756,546.12492,920,297.82
  收到的税费返还4,963,589.873,708,973.081,550,598.575,535,005.08
  收到其他与经营活动有关的现金28,857,588.7818,208,955.727,771,632.2940,895,944.8
  经营活动现金流入小计451,715,185.39281,252,796.67128,078,776.98539,351,247.7
  购买商品、接受劳务支付的现金130,668,143.9578,928,149.4335,047,705.46161,717,483.11
  支付给职工以及为职工支付的现金179,647,631.85124,075,199.2467,052,885.29241,642,844.21
  支付的各项税费11,799,948.158,623,129.883,223,408.1410,701,325.14
  支付其他与经营活动有关的现金47,085,149.0330,200,189.3824,631,085.9944,426,065.49
  经营活动现金流出小计369,200,872.98241,826,667.93129,955,084.88458,487,717.95
  经营活动产生的现金流量净额82,514,312.4139,426,128.74-1,876,307.980,863,529.75
二、投资活动产生的现金流量:
  收回投资收到的现金20,000,00020,000,00010,000,000619,392,000
  取得投资收益收到的现金105,380.53105,380.5359,178.083,435,499.97
  处置固定资产、无形资产和其他长期资产收回的现金净额---145,864
  投资活动现金流入小计20,105,380.5320,105,380.5310,059,178.08622,973,363.97
  购建固定资产、无形资产和其他长期资产支付的现金30,394,584.7117,276,315.26,339,135.58109,403,592.82
  投资支付的现金23,300,00010,000,00010,000,000558,392,000
  投资活动现金流出小计53,694,584.7127,276,315.216,339,135.58667,795,592.82
  投资活动产生的现金流量净额-33,589,204.18-7,170,934.67-6,279,957.5-44,822,228.85
三、筹资活动产生的现金流量:
  取得借款收到的现金25,664,755.5820,664,755.587,653,171.3419,654,670.89
  筹资活动现金流入小计25,664,755.5820,664,755.587,653,171.3419,654,670.89
  偿还债务支付的现金17,653,171.3410,000,000-25,564,355.03
  分配股利、利润或偿付利息支付的现金45,726,520.92173,00090,00049,273,544.99
  支付其他与筹资活动有关的现金18,303,602.2513,751,858.96,231,483.5582,422,898.66
  筹资活动现金流出小计81,683,294.5123,924,858.96,321,483.55157,260,798.68
  筹资活动产生的现金流量净额-56,018,538.93-3,260,103.321,331,687.79-137,606,127.79
四、汇率变动对现金及现金等价物的影响2,251,028.462,110,7281,322,735.544,816,818.38
五、现金及现金等价物净增加额-4,842,402.2431,105,818.75-5,501,842.07-96,748,008.51
  加:期初现金及现金等价物余额38,748,947.1738,748,947.1738,748,947.17135,496,955.68
  期末现金及现金等价物余额33,906,544.9369,854,765.9233,247,105.138,748,947.17
补充资料:
  净利润-24,761,426.27-17,083,154.83
  资产减值准备-5,159,549.6-643,810.61
  固定资产和投资性房地产折旧-13,817,549.06-25,702,048.59
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-13,817,549.06-25,702,048.59
  无形资产摊销-246,229.07-457,672.51
  长期待摊费用摊销-21,408,810.13-28,571,817.53
  固定资产报废损失-76,317.06-287,018.07
  公允价值变动损失--3,313,005.94--4,971,768.04
  财务费用-2,061,838.73-4,459,644.41
  投资损失--105,380.53--3,435,499.97
  递延所得税--8,508,051.84--20,829,721.24
  其中:递延所得税资产减少--8,819,118.59--20,510,177.87
    递延所得税负债增加-311,066.75--319,543.37
  存货的减少-3,102,121.71--4,368,975.16
  经营性应收项目的减少--58,386,299.29-7,106,877.54
  经营性应付项目的增加-24,833,860.84-7,249,240.07
  其他-2,817,058.87--
  现金的期末余额-69,854,765.92-38,748,947.17
  减:现金的期初余额-38,748,947.17-135,496,955.68
  现金及现金等价物的净增加额-31,105,818.75--96,748,008.51
公告日期2025-10-302025-08-282025-04-292025-04-24
审计意见(境内)标准无保留意见
TOP↑